Provider review
Enhance.MD tirzepatide review
What Enhance.MD charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.
Read on Enhance.MD’s own pages on November 20, 2026: $329 per 4 weeks month to month, or $313, $296 and $280 a month on 12-, 24- and 48-week terms (billed every 48 weeks on the longest). It scores 79/100 under our written v4.1 scoring guide, #3 of 22 programs scored.
What is distinctive about this programme
Lab testing included is unusual
Enhance.MD's microdose programme is reported as including laboratory testing in the all-inclusive price. Most programmes in this category either omit lab work or leave it ambiguous, and it is one of the fields we mark unverified across almost every provider. An explicit inclusion is worth noting.
Delivery every twelve weeks rather than monthly also changes the practical experience — fewer cold-chain events, larger single shipments.
The microdose caveat applies in full
At 1 mg weekly, this programme sits below every dose used in SURMOUNT. The trials studied 5, 10 and 15 mg, and the effect rose with dose. No trial has measured what 1 mg produces over a trial-length period.
Enhance.MD is at least explicit that the programme is a microdose at a stated milligram figure, which is more than several competitors publish.
Standard programmes are upper-band
At $280 tirzepatide and $212 semaglutide on twelve-month plans, the standard programmes are above the market's lower band. Month-to-month is $329 and $249 respectively. The $280 tirzepatide figure sits just below brand Zepbound's $299 manufacturer-direct starter price, which is a narrow margin for a product without FDA approval.
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Tirzepatide microdose | $169 | Provider-reported |
| Semaglutide injectable | $212 | Provider-reported |
| Tirzepatide injectable | $280 | Provider-reported |
Where it holds up
- Laboratory testing explicitly included in the microdose programme
- States the microdose in milligrams rather than describing it vaguely
- Same price at all doses across programmes
- Twelve-weekly delivery reduces cold-chain handling events
Where it does not
- The 1 mg microdose sits below every dose studied in the trials
- Standard programmes are in the upper band at $280 and $212
- Tirzepatide pricing is close to brand Zepbound's manufacturer-direct rate
- Figures are third-party reported and not yet captured by us
| Field | Position |
|---|---|
| Membership | Separate and required |
| Dose structure | Escalates with dose or not established |
| Lowest captured figure | $169/mo, prepaid term |
| Evidence status | Third-party reported, pending our own capture |
| Pharmacy named to us | No — provider-reported only |
| Category | Points |
|---|---|
| Pricing transparency | 20 |
| Total annual cost | 20 |
| Clinical oversight | 15 |
| Pharmacy transparency | 15 |
| Support | 10 |
| Regulatory disclosure | 10 |
| Accessibility | 10 |
Pricing, all-in
Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.
| Provider | Program | Formulation | Dose coverage | Medication | Required fees | All-in monthly | Price type | Evidence | Captured |
|---|---|---|---|---|---|---|---|---|---|
| Enhance.MD | prepaid | compounded injectable | not recorded | $280 | not verified | $280 | Commitment tier | Provider-reported | 2026-07-06 |
| Enhance.MD | prepaid | compounded microdose | not recorded | $169 | not verified | $169 | Commitment tier | Provider-reported | 2026-07-06 |
| Enhance.MD | prepaid | compounded injectable | not recorded | $212 | not verified | $212 | Commitment tier | Provider-reported | 2026-07-06 |
How this sits against the market
The July 2026 all-provider chart that stood here has been retired. Current first-party prices for 28 compounded tirzepatide programs (read October 15, 2026; NexLife November 20, 2026) are on the price index.
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
| Cost component | Inside the advertised figure? | Charged anyway? |
|---|---|---|
| Medication | yes | yes |
| Membership or program fee | no | not verified |
| Shipping | no | not verified |
| Higher-dose surcharge | no | not verified |
| Initial consultation | no | not verified |
| Required laboratory work | no | not verified |
| Cancellation or restocking terms | no | not verified |
This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.
Show this figure as a table
| Item | This provider | Category median |
|---|---|---|
| All-in monthly | not captured | not captured |
| Membership fee | not captured | not captured |
| Rubric score | not captured | not captured |
What is included, and what is not
Where it holds up
- nothing verified yet
Where it does not
- nothing verified yet
Where it operates
State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.
Show this figure as a table
| Status | Records | Share |
|---|---|---|
| Researched and verified | 0 | 0% |
| Not yet researched | 51 | 100% |
Pharmacy and fulfilment
What changed
Show this figure as a table
| No events recorded. |
- no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.
How this compares to the category
Once enough providers are scored, this section reports where Enhance.MD sits against the median for each rubric category, not against a hand-picked competitor.
| Question | Worth | Their answer | Status |
|---|---|---|---|
| Pharmacy traceability and quality disclosures | 15 pts | not verified | Not answered Verification pending |
| Clinical oversight and care continuity | 20 pts | not verified | Not answered Verification pending |
| State access and operational reliability | 10 pts | not verified | Not answered Verification pending |
| Cancellation, billing and support transparency | 10 pts | not verified | Not answered Verification pending |
Questions readers actually ask
Is Enhance.MD the cheapest option?
Read on its own page on November 20, 2026: $329 per 4 weeks month to month, or $313, $296 and $280 a month on 12-, 24- and 48-week terms (billed every 48 weeks on the longest).
Is compounded tirzepatide the same as Zepbound?
Enhance.MD scores 79/100 under the written v4.1 scoring guide, #3 of 22 programs scored from pages read November 20–21, 2026. Its weakest category is total annual cost (8 of 20).
Related on this site
- All provider reviewsProviders
- NexLife Tirzepatide ReviewProviders
- Ro Body Tirzepatide ReviewProviders
- Hims & Hers Tirzepatide ReviewProviders
- How rankings are computedCore & Trust
- All-in cost toolTools
- Price records, machine-readableData
- Advertising and Sponsored Content PolicyCore & Trust
- bmiMD Tirzepatide ReviewProviders
- WeightWatchers Clinic Tirzepatide ReviewProviders
Related coverage
- Embody: what we hold
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- CMS Delays the BALANCE Model Indefinitely and Extends the GLP-1 Bridge Instead
- A 2026 Study Finds Tirzepatide and B12 Can Chemically Bond — Forming a Molecule Not in the Approved Drug
- EVOKE and EVOKE+: Oral Semaglutide Made No Difference to Alzheimer's Progression
- FDA Sends 25 More Warning Letters Over Compounded GLP-1 Marketing Claims
- FDA Proposes Permanent Exclusion of Semaglutide, Tirzepatide and Liraglutide From the 503B Bulks List
- Comment Period on the GLP-1 Bulks Proposal Extended to 30 July
GLP-1 Tirzepatide Review. “Enhance.MD Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/providers/enhance-md/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.